Camilla Andersson
Directeur/Bestuurslid bij H. LUNDBECK A/S
Oorsprong van het eerstegraads netwerk van Camilla Andersson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
26
| Non-Profit Organization | Miscellaneous Commercial Services | 26 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Camilla Andersson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Sales & Marketing Chief Executive Officer President Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| University of Copenhagen | College/University | Director/Board Member Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Sales & Marketing Public Communications Contact | |
| Copenhagen Business School | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal President | |
| University of Aalborg | College/University | Graduate Degree Undergraduate Degree | |
| FRESENIUS MEDICAL CARE AG | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
| Leem | Founder Director/Board Member | ||
UCB Celltech
 UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member President | |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| DFDS A/S | Marine Shipping | Director/Board Member Director/Board Member | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Chief Executive Officer Chief Executive Officer | |
| Wallon Institute for Life Lead Sciences | Director/Board Member Director/Board Member | ||
| TDC A/S | Major Telecommunications | Director/Board Member Director/Board Member | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | Chairman General Counsel | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Founder Director/Board Member | |
Falck A/S
 Falck A/S Services to the Health IndustryHealth Services Falck A/S offers emergency assistance, rescue, healthcare, and training services. It provides emergency medical services to people through their ambulances, fire-fighting, fire training, and consultancy services to industrial customers; assistance in airports within the areas of fire services and personal assistance to travelers; and fire services and emergency services in airports. The firm also facilitates roadside assistance in case of an accident or breakdown of cars, trucks, busses, caravans, trailers, bicycles, motorcycles, and boats; travel assistance services to leisure travelers, business travelers, and expatriates; and fleet management services, as well as installs and services alarms in private homes and places of businesses. It also owns shares or other securities of domestic and foreign companies. The company was founded on August 23, 2004 and is headquartered in Copenhagen, Denmark. | Services to the Health Industry | Director/Board Member Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| COLOPLAST A/S | Medical Specialties | Director of Finance/CFO Chairman | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Comptroller/Controller/Auditor | |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Cape Town | College/University | Undergraduate Degree Undergraduate Degree | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Shire International GmbH
 Shire International GmbH Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a Swiss company that wholesales pharmaceutical products. | Medical Distributors | Corporate Officer/Principal | |
| Union College (New York) | College/University | Undergraduate Degree | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
| RECORDATI | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Denemarken | 16 |
| Verenigde Staten | 13 |
| Zwitserland | 7 |
| Duitsland | 5 |
| Frankrijk | 5 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 294 |
| Corporate Officer/Principal | 148 |
| Chairman | 93 |
| Chief Executive Officer | 79 |
| Independent Dir/Board Member | 77 |
Sterkste connecties
| Insiders | |
|---|---|
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Joseph Jimenez | 32 |
| Dieter Weinand | 32 |
| Marc M. P. de Garidel | 31 |
| Ian Read | 29 |
| Peter Andersen | 26 |
| Jeffrey Berkowitz | 26 |
| Ulf Arne Wiinberg | 26 |
| Stefan Oschmann | 23 |
| Lars Søren Rasmussen | 22 |
| Andreas Fibig | 21 |
| Deborah Dunsire | 20 |
| Lars Erik Holmqvist | 20 |
| Lene Skole-Sørensen | 20 |
| Jeremy Levin | 18 |
- Beurs
- Insiders
- Camilla Andersson
- Bedrijfsconnecties
